- Jump-To:
- Info & Features
- Reviews
Specialty drug spend is the single fastest growing healthcare expense. Recognizing the potential clinical value of these drugs, plan sponsors want to provide them to their enrollees—but to maintain an affordable, sustainable benefit in this rapidly changing environment, they must also control costs. To do this, plan sponsors need quantitative information about which strategies work to target drugs to those in need of them and they must minimize use of clinically ineffective therapies and reduce waste. However, the guidance and services prov ...
Profile
Support
Implementation
Product
Potential
People
Communications
Technology
Vision
Data
Flexibility
Create a free account to instantly unlock full reviews breakdown and to read reviews.